Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21243382 | 0.91 | TRPM8 (0.36) | LMNAMAPTTRPM8TP53CYP3A4 | |
| SCHEMBL21243334 | 0.86 | CYP1A2 (0.48) | HTTLMNAMAPK1MAPTCYP1A2 | |
| SCHEMBL21243329 | 0.86 | TP53 (0.41) | LMNATRPM8TP53CYP3A4 | |
| SCHEMBL21243358 | 0.84 | TRPM8 (0.38) | LMNATRPM8TP53CYP3A4 | |
| SCHEMBL21243337 | 0.81 | LIPA (0.39) | HTTMAPTGAATRPM8TP53 | |
| SCHEMBL21243331 | 0.80 | TP53 (0.46) | LMNATRPM8TP53CYP3A4MEN1 | |
| SCHEMBL21243363 | 0.79 | MAPT (0.43) | HTTLMNAMAPK1MAPTCYP1A2 | |
| SCHEMBL1196090 | 0.78 | ALDH1A1 (0.44) | LMNAPOLBHPGDTRPM8NAAA | |
| SCHEMBL21243375 | 0.78 | TRPM8 (0.41) | LMNATRPM8TP53CYP3A4 | |
| SCHEMBL1196205 | 0.77 | PPM1B (0.44) | TRPM8TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | DNAH12, DYNC1LI1, DYNC1LI2 | HTT 2085/4885LMNA 2553/4885MAPK1 1043/4885 |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | DNAH12, DYNC1LI1, DYNC1LI2 | HTT 2085/4885LMNA 2553/4885MAPK1 1043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.